Articaine Hydrochloride/Epinephrine Bitartrate

盐酸阿替卡因/重酒石酸肾上腺素

Report date: 2026/03/17 20:00:15

Base Information

Drug NameArticaine Hydrochloride/Epinephrine Bitartrate
Drug Alias NameEpinephrine Bitartrate and Articaine Hydrochloride盐酸阿替卡因重酒石酸肾上腺素酒石酸肾上腺素盐酸阿替卡因Epinephrine Bitartrate/Articaine Hydrochloride阿替卡因肾上腺素注射液 +[8] 
ClassificationSmall molecules
Mechanisms of ActionSodium channel alpha subunit modulatorsBeta adrenergic receptors agonistsAdrenergic receptor alpha-1 agonists
TargetsSodium channel alpha subunitBeta adrenergic receptorsAdrenergic receptors alpha-1
Therapy Area/IndicationsDental CariesPeriapical PeriodontitisAnesthesia
Global Approved IndicationsAnesthesia
Approved Indications in ChinaAnesthesia
Original Approved Country/TerritoryGermany
Original Approved Date1976/01/01
Country/TerritoryUnited StatesGermanyFrance +[5] 
CombinationsYes Epinephrine BitartrateArticaine Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSeptodont Inc
China Registration ClassN/A

Develop Information

Active CompaniesSeptodont IncDeproco IncShowa Yakuhin Kako Co Ltd
Inactive CompaniesVirginia Commonwealth University
Active IndicationsAnesthesia
Inactive IndicationsDental CariesPeriapical Periodontitis

Other Information

ATC CodeN01BB58
Related LinksN/A